Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-01 03:22 | 2018-08-29 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | OPT+S | $135.08 | 3,000 | $405,237 | 15,667 | -16.1% |
| 2018-08-09 01:30 | 2018-08-06 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | OPT+S | $150.16 | 10,000 | $1,501,600 | 152,296 | -6.2% |
| 2018-05-04 03:15 | 2018-05-01 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | OPT+S | $125.69 | 5,000 | $628,456 | 12,225 | -29.0% |
| 2018-03-15 00:06 | 2018-03-12 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $121.03 | 10,000 | $1,210,300 | 160,775 | -5.9% |
| 2018-03-06 05:06 | 2018-03-01 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | OPT+S | $108.44 | 5,000 | $542,185 | 12,225 | -29.0% |
| 2018-01-05 04:36 | 2018-01-02 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $89.89 | 40,000 | $3,595,768 | 166,296 | -19.4% |
| 2017-09-30 01:50 | 2017-09-27 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $90.03 | 20,017 | $1,802,183 | 206,296 | -8.8% |
| 2017-09-23 01:01 | 2017-09-20 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $90.00 | 4,983 | $448,470 | 226,313 | -2.2% |
| 2017-08-12 01:09 | 2017-08-09 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $85.15 | 10,000 | $851,503 | 231,296 | -4.1% |
| 2017-04-27 01:14 | 2017-04-24 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | OPT+S | $85.24 | 10,000 | $852,400 | 241,296 | -4.0% |
| 2017-03-04 01:03 | 2017-03-01 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $80.03 | 5,000 | $400,150 | 246,296 | -2.0% |
| 2017-02-15 02:43 | 2017-02-14 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $75.00 | 5,000 | $375,000 | 251,296 | -2.0% |
| 2017-02-11 03:22 | 2017-02-08 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $71.03 | 4,899 | $347,977 | 256,296 | -1.9% |
| 2017-02-09 05:12 | 2017-02-06 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $70.00 | 101 | $7,070 | 261,195 | 0.0% |
| 2017-02-04 04:20 | 2017-02-01 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $70.35 | 5,000 | $351,765 | 261,296 | -1.9% |
| 2016-09-07 04:15 | 2016-09-01 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $70.10 | 3,100 | $217,319 | 266,296 | -1.2% |
| 2016-09-01 04:31 | 2016-08-29 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $71.17 | 5,300 | $377,189 | 269,396 | -1.9% |
| 2016-08-30 03:43 | 2016-08-25 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $71.03 | 5,300 | $376,448 | 274,696 | -1.9% |
| 2016-08-25 04:19 | 2016-08-22 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $73.00 | 6,300 | $459,896 | 279,996 | -2.2% |
| 2016-05-24 02:36 | 2016-05-20 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | SALE | $50.52 | 5,000 | $252,585 | 286,296 | -1.7% |
| 2016-05-24 02:36 | 2016-05-19 | PEN | Penumbra Inc | Evans Robert D. | Officer; EVP, Gen. Counsel & Secretary | Surgical & Medical Instruments & Apparatus | BUY | $25.50 | 1,538 | $39,219 | 2,538 | +153.8% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.